Skip to main content
. Author manuscript; available in PMC: 2018 Feb 1.
Published in final edited form as: Mol Cancer Ther. 2016 Nov 30;16(2):376–387. doi: 10.1158/1535-7163.MCT-16-0381

Figure 2. Correlation of microdose-induced [14C]carboplatin-DNA adduct levels to therapy response.

Figure 2

Carboplatin-DNA monoadduct levels were quantified in patient A) PBMC and B) tumor biopsy tissue 24 h after receiving one microdose of [14C]carboplatin (grey circular symbols = responder, grey dashed line = responder mean adduct level, black symbols = non-responders, black solid line = non-responder mean adduct level). Student's t-test was used to measure all p values (p<0.001 for high adduct level group compared to the low adduct level group, and p = 0.069 for differentiating responders and nonresponders). Each data point represents a value for an individual patient.